See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2018_BELLICUM_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001358403, BELLICUM PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,650,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 25,942,000 |
| 3 | remainder_Assets | 7,936,000 |
| 4 | LiabilitiesCurrent | 12,156,000 |
| 5 | LiabilitiesNoncurrent | 34,946,000 |
| 6 | remainder_Liabilities | 3,778,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,045,000 |
| 9 | ResearchAndDevelopmentExpense | 65,663,000 |
| 10 | remainder_Expenses | 864,000 |
| 11 | remainder_Revenues | 185,000 |
| 12 | remainder_NetIncome | -4,392,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 135,528,000 |
| 1 | Liabilities | 50,880,000 |
| 2 | Expenses | 87,572,000 |
| 3 | Revenues | 185,000 |
| 4 | StockholdersEquity | 84,648,000 |
| 5 | NetIncome | -91,779,000 |
| 6 | ComprehensiveNetIncome | -91,779,000 |
| 7 | BaseVar | 139,278,500 |
| 8 | EconomicCapitalRatio | 0.577 |